Company / Gross Profit
Co-Diagnostics, Inc. Gross Profit History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$400.1K
FY2025
5-year range
$400.1K / $86.3M
FY2021-FY2025
Trend
-86.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 9 years, ranging from $7,360 in FY2018 to $86M in FY2022.
Based on SEC 10-K filings.
$400,112 in FY2025 with a 5-year CAGR of +31.3%.
Declined from $3M to $400,112 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -83.3%
- 5-Year CAGR
- +31.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +31.3%, indicating consistent growth.
- In FY2025, gross profit decreased 86.3% year-over-year.
- Peak gross profit was recorded in FY2022.
- Lowest gross profit in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $400.1K | -86.3% |
| FY2024 | $2.9M | +11.0% |
| FY2023 | $2.6M | -97.0% |
| FY2022 | $86.3M | +48.9% |
| FY2021 | $58.0M | +56424.0% |
| FY2020 | $102.5K | +236.0% |
| FY2019 | $30.5K | +314.7% |
| FY2018 | $7.4K | +0.0% |
| FY2017 | $7.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026